News

Utrecht University researchers Bas van Ravensteijn and Markus Weingarth have each been awarded an ERC Proof of Concept Grant of €150.000 to further enhance antibiotics and nanomedice ...
For decades, the dream of fixing harmful mutations in mitochondrial DNA felt out of reach. Scientists have long known these ...
In contrast, protein expression was detected only following intramuscular injection of mRNA-loaded nanoparticles with a PEG/polymer ratio of 10:1. These findings suggest that the PEG density on the ...
The global lipid nanoparticles (LNP) contract development and manufacturing organization (CDMO) market is poised for substantial double-digit growth by 2027, driven by the growing acceptance of LNPs ...
When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...
Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines, recently hosted the "2025 ...
AbbVie is acquiring Capstan Therapeutics, a startup with technology that enables in vivo engineering of immune cells.
Only a few studies have investigated the use of poly (sarcosine) (pSar) or poly (2-ethyl-2-oxazoline) (pEtOx) for coating lipid nanoparticles (26−28) and polyplexes. (29−33) In the present study, we ...
A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized ...
Genprex's oncology program utilizes its systemic, non-viral Oncoprex ® Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form.